secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2025-11-07T23:59:59+00:00
Accession:  0001628280-25-050683
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn Therapeutics releases November 2025 investor presentation highlighting precision therapeutics
--------------------------------------------------------------------------------

- Presentation dated November 2025 focuses on the company's unique biology and precision therapeutics platform.
- No specific financial results or operational updates disclosed in the filing.
- The presentation is intended for use in meetings with investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828025050683/0001628280-25-050683-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828025050683/fhtx-20251107.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-050683

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer